Close

Refine your search

Slogan of Faculty of Health Sciences.

Kuopio Brain & Mind´s Translational Research Networking Event

  • Discussion event
  • Health and well-being
Event date:
Time:
12:00–16:00
Event location:
Kuopio University Hospital, M-building, 2nd floor, Auditorium 2, and online
Add to calendar:
Google Outlook iCal

Kuopio Brain & Mind brings together and fosters collaboration among basic and clinical researchers, medical doctors and other experts, and all interested in promoting translational neuroscience research.

In this event you hear about ongoing translational research and training projects and discuss what is needed for successful collaboration:

Applications of translational medicine in early-stage Alzheimers´s desease research
Presented by Mikko Hiltunen

Multiscale asessment of epileptogenicity
Presented by Reetta Kälviäinen and Alejandra Sierra Lopez

Biological edolescent psychiatry
Presented by Tommi Tolmunen

Neuro-innovation doctoral and novel MSCA postdoctoral programmes
Presented by Tarja Malm

Register by 21 March. Welcome on-site! Link for on-line participants will be sent via email closer to the event.

For further information, please contact Tarja Laitinen, Regional Manager Kuopio Brain & Mind, email tarja.laitinen@uef.fi.

 

Wellbeing services county of North Savo logo

Related content

placeholder-image

UEF Brain Research Unit 2.0

Ongoing

The Brain Research Unit of the University of Eastern Finland (BRU) conducts high-quality clinical research as well as pharmaceutical research and collaboration with local, Finnish, and international research groups and the pharmaceutical industry. Specifically, the area of expertise in BRU includes biomarker studies, clinical trials and prevention studies of neurodegenerative diseases and cerebrovascular disorders. BRU also has the capability to investigate the genetic background, risk factors and basic mechanisms of brain diseases. Importantly, BRU has 20 years of experience, and it operates national and international collaborative networks. BRU with its collaborative network provides a service to the international or domestic pharmaceutical industry in research from the basic research to clinics. The aim of the UEF Brain Research Unit 2.0 ERDF project is to create a well-known, internationally attractive, and scalable operating model and brand in collaboration with UEF, KUH (Kuopio University Hospital) and companies. This strengthens the local Kuopio Health ecosystem and utilizes the extensive national and international network of the Neurocenter Finland and other stakeholders. The key operating processes will be strengthen based on the needs identified from business field by identifying bottlenecks, which are limiting cooperation as well as opportunities for new cooperation openings and partnering. Solution options are sought in ecosystem cooperation and tested by business-driven co-development (three piloting cases) and further development of internal processes and cooperation (three work packages), as well as identifying new commercialization potential in both organizational and operational environment level. UEF Brain Research Unit 2.0 is a new and scalable approach to multifunctional cooperation. The ERDF project creates, by further developing existing and new activities, nationally and internationally competitive forms of cooperation and structures that better serve the global the needs of pharmaceutical companies, equipment manufacturers, health technology operators and high-quality academic research. Furthermore, the project creates a plan to further develop activities, to meet the new updating needs created by the societal framework of clinical research and digitalization.

Read more

Research group picture: Clinical Alzheimer Research

Clinical Alzheimer Research

Ongoing

Clinical Alzheimer Research groups have a wide expertise in clinical and population based cohorts, risk factors, neuropsychology, biomarkers, genetics, brain imaging, and clinical interventions and trials in AD and mild cognitive impairment. Research groups have been involved in national and international consortia such as FINGER, ADDNeuroMed, PREDICTND, LipiDiDiet, HATICE, EMIF, GWAS-consortia as well as Joint Program of Neurodegenerative Diseases (JPND) MIND-AD. Groups have trained staff, and state of the art facilities, extensive administrative experience and track record of leading large research projects. They have also clinical and risk factor data, samples of blood, CSF and DNA collected in cross-sectional and longitudinal studies in memory diseases. Biomarker laboratory is run by Sanna-Kaisa Herukka, MD, PhD. The Neurology Unit has over twenty years’ experience in CSF biomarker studies. There is a large biobank including CSF and blood samples from controls and patients with neurodegenerative diseases, particularly AD. In 2005, we established a national biomarker laboratory service available for Finnish physicians and hospitals. The quality management system of the laboratory is based on the international standards for quality management and for clinical laboratories. The quality management system has been audited by laboratory professionals from another testing laboratory and internal audits are performed according to the audit program of UEF. The laboratory also takes part in several large scale international studies on CSF biomarkers for AD.

Read more